Uzkeser et al, however, investigated the serum HTATIP2/TIP30 levels in patients with rheumatoid arthritis, ankylosing spondylitis, and sarcoidosis, referring to the role of inflammation in the cancer pathogenesis. This evidence concerns the gene HTATIP2 and ankylosing spondylitis.